Israeli technological breakthroughs always on the cutting edge…
Israeli scientist claims he’s two-thirds the way to COVID-19 vaccine
Despite claim and if successful, a vaccine would take over a year to develop. It will target the virus’s Receptor Binding Motif (RBM), a critical weak point.
Prof. Jonathan Gershoni from Tel Aviv University’s (TAU) School of Molecular Cell Biology and Biotechnology claimed on Sunday that work his laboratory is doing on the corona family of viruses is “two-thirds of the way” through the process of developing a vaccine for COVID-19.
Gershoni, who has studied the family of viruses for 15 years, said that he was recently granted a patent by the United States Patent and Trademark Office for his vaccine design. He explained that the vaccine intends to target the virus’s Receptor Binding Motif (RBM), a critical weak point which allows the virus to attach itself and infect a target cell.